Table 10. Univariate and Multivariate analyses to predict Stent Thrombosis.
| Variable | Univariate Analysis |
Multivariate Analysis |
||
|---|---|---|---|---|
| HR [95% CI] | P | HR [95%CI] | P | |
| Age | 1.04 [0.99–1.08] | 0.05 | 1.015 [0.974–1.058] | 0.471 |
| Sex | 0.75 [0.21–2.66] | 0.66 | ||
| STEMI | 1.17 [0.43–3.23] | 0.76 | ||
| NSTEMI | 1.33 [0.48–3.66] | 0.59 | ||
| Smoking | 0.61 [0.21–1.78] | 0.36 | ||
| Diabetes | 1.99 [0.71–5.60] | 0.19 | ||
| Hypertension | 0.94 [0.34–2.58] | 0.89 | ||
| Family history of coronary artery disease | 2.21 [0.75–6.46] | 0.15 | ||
| Dyslipidemia | 1.10 [0.40–3.04] | 0.85 | ||
| BMI > 30 | 1.17 [0.37–3.68] | 0.79 | ||
| Prior STEMI | 0.37 [0.05–2.79] | 0.33 | ||
| Prior NSTEMI | 0.89 [0.12–6.74] | 0.91 | ||
| Prior PCI | 0.62 [0.14–2.74] | 0.53 | ||
| Prior CABG | 1.33 [0.17–10.09] | 0.79 | ||
| History of stroke | 1.41 [0.19–10.76] | 0.74 | ||
| Peripheral vascular disease | 1.60 [0.36–7.11] | 0.53 | ||
| CKD | 1.17 [0.15–8.92] | 0.88 | ||
| Killip 2 to 4 | 2.28 [0.64–8.07] | 0.20 | ||
| Left ventricular ejection fraction | 0.97 [0.93–1.01] | 0.19 | ||
| Clopidogrel | 2.23 [0.63–7.91] | 0.211 | ||
| ACE-inhibitor | 0.28 [0.08–1.004] | 0.05 | ||
| Statin | 0.075 [0.024–0.24] | 0.0001 | ||
| HbA1c | 1.27 [0.99–1.63] | 0.06 | ||
| Troponin at admission | 1.006 [0.99–1.01] | 0.10 | ||
| CRP at admission | 1.013 [1.004–1.022] | 0.005 | 1.013 [1.004–1.023] | 0.005 |
| Three vessel | 3.26 [1.18–9.00] | 0.02 | 1.733 [0.538–5.581] | 0.357 |
| Stent number | 1.74 [1.25–2.43] | 0.001 | 1.661 [1.097–2.514] | 0.016 |
| Hemorrhagic events | 5.44 [1.21–24.46] | 0.03 | 6.429 [1.349–30.633] | 0.019 |
HR = Hazard ratio; CI = confidence interval
ACE = angiotensin-converting enzyme; BMI = body mass index; BNP = brain natriuretic peptide; CRP = C-reactive protein; DES = drug eluting stent; NSTEMI = Non ST segment elevation myocardial infarction; STEMI = ST segment elevation myocardial infarction